|
All Clinical trials
Citations 191-200 of 604 total displayed.
|
Past content
(since Jan 2000):
|
- ARTICLES
Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial
- P. Kaufmann, K. Engelstad, Y. Wei, S. Jhung, M. C. Sano, D. C. Shungu, W. S. Millar, X. Hong, C. L. Gooch, X. Mao, J. M. Pascual, M. Hirano, P. W. Stacpoole, S. DiMauro, and D. C. De Vivo
Neurology 2006; 66: 324-330.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial
- Huntington Study Group
Neurology 2006; 66: 366-372.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Randomized placebo-controlled study of the nicotinic agonist SIB-1508Y in Parkinson disease
- The Parkinson Study Group
Neurology 2006; 66: 408-410.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis
- F. Göngora-Rivera, J. L. Soto-Hernández, D. González Esquivel, H. J. Cook, C. Márquez-Caraveo, R. Hernández Dávila, and J. Santos-Zambrano
Neurology 2006; 66: 436-438.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine
- M. C. Post, V. Thijs, W. J. Schonewille, W. Budts, R. J. Snijder, H.W.M. Plokker, and C. J.J. Westermann
Neurology 2006; 66: 202-205.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury
- F. Giuliano, E. Rubio-Aurioles, M. Kennelly, F. Montorsi, E. D. Kim, A. E. Finkbeiner, P. J. Pommerville, M. W. Colopy, H. J. Wilkins, B. H. Wachs for the Vardenafil Study Group
Neurology 2006; 66: 210-216.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG
- S. M. Hersch, S. Gevorkian, K. Marder, C. Moskowitz, A. Feigin, M. Cox, P. Como, C. Zimmerman, M. Lin, L. Zhang, A. M. Ulug, M. F. Beal, W. Matson, M. Bogdanov, E. Ebbel, A. Zaleta, Y. Kaneko, B. Jenkins, N. Hevelone, H. Zhang, H. Yu, D. Schoenfeld, R. Ferrante, and H. D. Rosas
Neurology 2006; 66: 250-252.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Coenzyme Q10 deficiency and isolated myopathy
- R. Horvath, P. Schneiderat, B.G.H. Schoser, K. Gempel, E. Neuen-Jacob, H. Plöger, J. Müller-Höcker, D. E. Pongratz, A. Naini, S. DiMauro, and H. Lochmüller
Neurology 2006; 66: 253-255.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Substrate reduction therapy in the infantile form of Tay-Sachs disease
- B. Bembi, F. Marchetti, V. I. Guerci, G. Ciana, R. Addobbati, D. Grasso, R. Barone, R. Cariati, L. Fernandez-Guillen, T. Butters, and M. G. Pittis
Neurology 2006; 66: 278-280.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Gentamicin treatment in McArdle disease: Failure to correct myophosphorylase deficiency
- A. Schroers, R. A. Kley, A. Stachon, R. Horvath, H. Lochmüller, J. Zange, and M. Vorgerd
Neurology 2006; 66: 285-286.
[Full text]
[PDF]
|
|
